EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol Add-On in Glycosylphosphatidylinositol-Related Drug-Resistant Epilepsy

Antonella Riva iD, Gianluca D'Onofrio, Angelica Pisati, Roberta Roberti, Elisabetta Amadori, Friedrich Bosch, Carolina Fischinger Moura de Souza, Ashley Thomas, Emilio Russo, Pasquale Striano, Allan Bayat

Cannabis and Cannabinoid Research · 2024

DOI: 10.1089/can.2022.0255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cannabis and Cannabinoid Research, 2024. Verfasst von Antonella Riva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Cannabidiol, Glycosylphosphatidylinositols, Anticonvulsants. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyCannabidiolGlycosylphosphatidylinositolsAnticonvulsantsHumansMaleFemaleInfantChild, PreschoolTreatment OutcomeChildDrug Therapy, CombinationSeizures

Stichwörter der Autor:innen

GPIPIG’opathycannabidioldrug-resistant epilepsyepileptic encephalopathy

Substanzen

CannabidiolGlycosylphosphatidylinositolsAnticonvulsants

Autor:innen und Institutionen

  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
  • Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto "Giannina Gaslini," Genoa, Italy.
  • Department of Science of Health, School of Medicine, University of Catanzaro, Catanzaro, Italy.
  • Children's Hospital, Fürth, Germany.
  • Medical Genetics Service, HCPA, Porto Alegre, Brazil.
  • University of Alabama, Birmingham, Alabama, USA.

ORCID-Profile: Antonella Riva

Zitieren

APA

Riva, A., D'Onofrio, G., Pisati, A., Roberti, R., Amadori, E., Bosch, F., de Souza, C. F. M., Thomas, A., Russo, E., Striano, P., & Bayat, A. (2024). Cannabidiol Add-On in Glycosylphosphatidylinositol-Related Drug-Resistant Epilepsy. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2022.0255

Vancouver

Riva A, D'Onofrio G, Pisati A, Roberti R, Amadori E, Bosch F, et al. Cannabidiol Add-On in Glycosylphosphatidylinositol-Related Drug-Resistant Epilepsy. Cannabis and Cannabinoid Research. 2024. doi:10.1089/can.2022.0255

BibTeX
@article{Riva2024,
  author = {Riva, Antonella and D'Onofrio, Gianluca and Pisati, Angelica and Roberti, Roberta and Amadori, Elisabetta and Bosch, Friedrich and de Souza, Carolina Fischinger Moura and Thomas, Ashley and Russo, Emilio and Striano, Pasquale and Bayat, Allan},
  title = {Cannabidiol Add-On in Glycosylphosphatidylinositol-Related Drug-Resistant Epilepsy},
  journal = {Cannabis and Cannabinoid Research},
  year = {2024},
  doi = {10.1089/can.2022.0255}
}
Kostenlos starten →